CNN – Three shots and 1 booster later, this man has little protection against Covid-19

By Christina Zdanowicz, CNN

Source: https://edition.cnn.com/2021/11/09/health/immunocompromised-covid-19-booster-wellness-trnd/index.html

(CNN)Double-masking, staying at home nearly 24/7 and rarely seeing people beyond his wife are still the way of life for kidney transplant recipient Andrew Linder, even after many in the United States are living like the pandemic has ended.Health officials are recommending third and even fourth shots to boost Covid-19 resistance for people with certain conditions, but that hasn’t eased the fears of some immunocompromised people.Linder, 34, received the life-changing gift of a kidney from his wife, Emily, in September 2019. He will be on immunosuppressants for the rest of his life to keep his body from rejecting the organ.In March 2020, as Covid-19 cases started to shut down workplaces and cities, Emily moved in with her parents for months because she works with the homeless and people in the prison system and did not want to get her husband sick.Andrew and Emily Linder got hitched a month before she gave him a kidney.Andrew and Emily Linder got hitched a month before she gave him a kidney.The coronavirus vaccines brought some hope for the Linders, who live in Akron, Ohio. Andrew Linder had two doses of the Pfizer vaccine and later an additional dose and a booster. Hope quickly turned to heartbreak.”I had no antibodies whatsoever. That was shocking and scary and sucky for sure,” Linder told CNN. “I almost feel just as unsafe or if not potentially a little bit more unsafe now than at the beginning of the pandemic, just for the fact that I could get it at this point in time.”

The pandemic isn’t over for many

Linder is one of many moderately to severely immunocompromised people trying to protect themselves as a number of people across the US are going back to some version of their normal lives.The US Centers for Disease Control and Prevention estimates about 9 million people who live in the US, or about 3% of the population, are moderately to severely immunocompromised. That includes people in active treatment for cancers of the blood or for solid tumors, certain organ transplant and stem cell recipients, people with advanced or untreated HIV, and those who take high-dose corticosteroids or other drugs that may suppress their immune system.

A new study published by the CDC last week suggests people with compromised immune systems may need to receive three doses of a coronavirus vaccine and a booster shot to get as much protection afforded by two doses to those who are not immunocompromised. The effectiveness of the Pfizer and Moderna vaccines against Covid-19 hospitalization was 77% among immunocompromised adults versus 90% among immunocompetent adults.For transplant recipients like Linder and some other members of the immunocompromised community, the research showed that vaccine effectiveness was lower than that.

ZeroHedge – Study Reveals ‘Dramatic’ Decline In All Three COVID-19 Vaccines’ Efficacy Over Time

Sars: https://www.science.org/doi/10.1126/science.abm0620

SARS-CoV-2 vaccine protection and deaths among US veterans during 2021

Abstract

We report SARS-CoV-2 vaccine effectiveness against infection (VE-I) and death (VE-D) by vaccine type (n = 780,225) in the Veterans Health Administration, covering 2.7% of the U.S. population. From February to October 2021, VE-I declined from 87.9% to 48.1%, and the decline was greatest for the Janssen vaccine resulting in a VE-I of 13.1%. Although breakthrough infection increased risk of death, vaccination remained protective against death in persons who became infected during the Delta surge. From July to October 2021, VE-D for age 65 years was 73.0% for Janssen, 81.5% for Moderna, and 84.3% for Pfizer-BioNTech; VE-D for age ≥65 years was 52.2% for Janssen, 75.5% for Moderna, and 70.1% for Pfizer-BioNTech. Findings support continued efforts to increase vaccination, booster campaigns, and multiple, additional layers of protection against infection.

As shown in Fig. 2, risk of infection accelerated in both unvaccinated and fully vaccinated Veterans beginning in July 2021 and through September 2021, consistent with the time dependence observed in the Cox proportional hazards models. This pattern was similar across age groups, and risk of infection was highest for unvaccinated Veterans. Veterans who were fully vaccinated with the Moderna vaccine had the lowest risk of infection, followed closely by those who received the Pfizer-BioNTech vaccine, then those who received the Janssen vaccine.

Fig. 2. Kaplan-Meier curves illustrating cumulative risk of SARS-CoV-2 infection by vaccination status and age.(A) All ages. (B) Age <50 years. (C) Age 50-64 years. (D) Age ≥65 years. The survival function estimates time to infection detected by most recent RT-PCR assay.

Risk of death after SARS-CoV-2 infection was highest in unvaccinated Veterans regardless of age and comorbidity (Fig. 3). However, breakthrough infections were not benign, as shown by the higher risk of death in fully vaccinated Veterans who became infected compared to vaccinated Veterans who remained infection-free.

Fig. 3. Kaplan-Meier curves illustrating cumulative risk of death due to any cause by vaccination status and RT-PCR assay.(A) Age <65 years. (B) Age ≥65 years. (C) Charlson Comorbidity Index score <3. (D) Charlson Comorbidity Index score ≥3.

We observed similar results when examining the time period corresponding to the dominance of the Delta variant (fig. S1). Specifically, among those with a positive PCR test on or after July 1, 2021, vaccination was protective against death, although with some differences by age and vaccine type. For age <65 years, vaccine effectiveness against death (VE-D) was 81.7% (95% CI: 75.7% to 86.2%) for any vaccine; 73.0% (95% CI: 52.0% to 84.8%) for Janssen; 81.5% (95% CI: 70.7% to 88.4%) for Moderna; and 84.3% (95% CI: 76.3% to 89.7%) for Pfizer-BioNTech. For age ≥65 years, VE-D was 71.6% (95% CI: 68.6% to 74.2%) for any vaccine; 52.2% (95% CI: 37.2% to 63.6%) for Janssen; 75.5% (95% CI: 71.8% to 78.7%) for Moderna; and 70.1% (95% CI: 66.1% to 73.6%) for Pfizer-BioNTech.

Source: https://www.zerohedge.com/covid-19/study-reveals-dramatic-decline-all-three-covid-19-vaccines-over-time

Swedish Study: Covid Jabs Provide No Lasting Protection – Immunity Plunges To ZERO In Mere Months

The Lancet – Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study

Source: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3949410

New research out of Sweden has found that post-vaccination “immunity” – if you can even call it that – from Wuhan coronavirus (Covid-19) injections is temporary at best, and completely gone within months.

Abstract

Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19) lasts longer than 6 months is unclear.

Methods: A retrospective cohort study was conducted using Swedish nationwide registries. The cohort comprised 842,974 pairs (N=1,684,958), including individuals vaccinated with 2 doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2, and matched unvaccinated individuals. Cases of symptomatic infection and severe Covid-19 (hospitalization or 30-day mortality after confirmed infection) were collected from 12 January to 4 October 2021. 

Findings: Vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07). The effectiveness waned slightly slower for mRNA-1273, being estimated to 59% (95% CI, 18-79) from day 181 and onwards. In contrast, effectiveness of ChAdOx1 nCoV-19 was generally lower and waned faster, with no effectiveness detected from day 121 and onwards (-19%, 95% CI, -97-28), whereas effectiveness from heterologous ChAdOx1 nCoV-19 / mRNA was maintained from 121 days and onwards (66%; 95% CI, 41-80). Overall, vaccine effectiveness was lower and waned faster among men and older individuals. For the outcome severe Covid-19, effectiveness waned from 89% (95% CI, 82-93, P<0·001) at day 15-30 to 42% (95% CI, -35-75, P=0·21) from day 181 and onwards, with sensitivity analyses showing notable waning among men, older frail individuals, and individuals with comorbidities.

Interpretation: Vaccine effectiveness against symptomatic Covid-19 infection wanes progressively over time across all subgroups, but at different rate according to type of vaccine, and faster for men and older frail individuals. The effectiveness against severe illness seems to remain high through 9 months, although not for men, older frail individuals, and individuals with comorbidities. This strengthens the evidence-based rationale for administration of a third booster dose.

Lithuania, on the other hand, which currently has the world’s strictest “vaccine passport” scheme, is seeing an all-time high of new “cases” per capita within its population.

Just six weeks after the mandatory jab protocol was put into place in Lithuania, infection rates skyrocketed like never before – far outpacing that of Sweden, which is pretty much covid-free at this point (see the image below for a comparison):

swedish study covid jabs provide no lasting protection – immunity plunges to zero in mere months

Just News – Moose Web Clients – Your EMF Guide : Creating a Radiation Free Bedroom Video : Leonard Stafford

Moose Web Clients – Your EMF Guide : Creating a Radiation Free Bedroom Video : Leonard Stafford

Your EMF Guide Video – Creating a Radiation Free Bedroom – Leonard Stafford

GPA shielding mesh provides effective protection against electronic pollution

GPA is a fibreglass mesh with metal woven through it that is coated in Geovital’s electrically conductive T98 Alpha shielding paint.

GPA reduces electromagnetic high frequency (RF) radiation exposure in buildings from common sources like mobile phone towers, wi-fi, smart meters, cordless phones, radar, airport navigation systems, etc. It can also be used to shield against low frequency electric fields, often produced by internal wiring.

GPA can be applied on walls, ceilings and potentially, flooring:

  • under timber cladding
  • placed inside wall, ceiling and floor structures
  • placed under carpet
  • as reinforcement mesh in ETIC systems
  • as reinforcement mesh in rendering

GPA provides effective shielding against electronic pollution. It can achieve a reduction of over 99% in the amount of high frequency (RF) radiation and reduces low frequency electric fields dramatically (See test report: University of German Armed Forces). As well as being alkali resistant, it has a high tensile strength.

 

Vaccine News – Study – Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors & VAXXED TV – Vaxxed versus unvaccinated in my family

A study conducted by the Department of Paediatrics at the University of Arkansas determined that thimerosal-induced cytotoxicity was associated with the depletion of intracellular glutathione (GSH) in both cell lines. The study outlines how many vaccines have been neurotoxic, especially to the developing brain. Depletion of GSH is commonly associated with autism. Although thimerosal has been removed from most children’s vaccines, it is still present in flu vaccines given to pregnant women, the elderly and to children in developing countries.

US National Library of Medicine
National Institutes of Health – 2005

Study – Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors.

James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S.
Author information
Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital Research Institute, Little Rock, AR 72202, USA. jamesjill@uams.edu

Abstract
Thimerosol is an antiseptic containing 49.5% ethyl mercury that has been used for years as a preservative in many infant vaccines and in flu vaccines. Environmental methyl mercury has been shown to be highly neurotoxic, especially to the developing brain. Because mercury has a high affinity for thiol (sulfhydryl (-SH)) groups, the thiol-containing antioxidant, glutathione (GSH), provides the major intracellular defense against mercury-induced neurotoxicity. Cultured neuroblastoma cells were found to have lower levels of GSH and increased sensitivity to thimerosol toxicity compared to glioblastoma cells that have higher basal levels of intracellular GSH. Thimerosal-induced cytotoxicity was associated with depletion of intracellular GSH in both cell lines. Pretreatment with 100 microM glutathione ethyl ester or N-acetylcysteine (NAC), but not methionine, resulted in a significant increase in intracellular GSH in both cell types. Further, pretreatment of the cells with glutathione ethyl ester or NAC prevented cytotoxicity with exposure to 15 microM Thimerosal. Although Thimerosal has been recently removed from most children’s vaccines, it is still present in flu vaccines given to pregnant women, the elderly, and to children in developing countries. The potential protective effect of GSH or NAC against mercury toxicity warrants further research as possible adjunct therapy to individuals still receiving Thimerosal-containing vaccinations.

A study conducted by the University of Texas Health Science Centre by the Department of Family and Community Medicine determined that for each 1,000 Ib of environmentally released mercury, there was a 43% increase in the rate of special education services and a 61% increase in the rate of autism. Researchers emphasized that further research was needed regarding the association between environmentally released mercury and developmental disorders such as autism.

US National Library of Medicine
National Institutes of Health – 2006

Study – Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas

Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C.
Author information
University of Texas Health Science Center, San Antonio Department of Family and Community Medicine, 7703 Floyd Curl Drive, San Antonio, Texas 78229-3900, USA. palmer@uthscsa.edu

Abstract
The association between environmentally released mercury, special education and autism rates in Texas was investigated using data from the Texas Education Department and the United States Environmental Protection Agency. A Poisson regression analysis adjusted for school district population size, economic and demographic factors was used. There was a significant increase in the rates of special education students and autism rates associated with increases in environmentally released mercury. On average, for each 1,000 lb of environmentally released mercury, there was a 43% increase in the rate of special education services and a 61% increase in the rate of autism. The association between environmentally released mercury and special education rates were fully mediated by increased autism rates. This ecological study suggests the need for further research regarding the association between environmentally released mercury and developmental disorders such as autism. These results have implications for policy planning and cost analysis.

A study published in the International Journal of Toxicology determined that in light of the biological plausibility of mercury’s role in neurodevelopment disorders, the present study provides further insight into one possible mechanism by which early mercury exposures could increase the risk of autism.

US National Library of Medicine
National Institutes of Health – 2003

Study – Reduced levels of mercury in first baby haircuts of autistic children

Holmes AS, Blaxill MF, Haley BE.
Author information
SafeMinds, Cambridge, Massachusetts, USA.

Abstract
Reported rates of autism have increased sharply in the United States and the United Kingdom. One possible factor underlying these increases is increased exposure to mercury through thimerosal-containing vaccines, but vaccine exposures need to be evaluated in the context of cumulative exposures during gestation and early infancy. Differential rates of postnatal mercury elimination may explain why similar gestational and infant exposures produce variable neurological effects. First baby haircut samples were obtained from 94 children diagnosed with autism using Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM IV) criteria and 45 age- and gender-matched controls. Information on diet, dental amalgam fillings, vaccine history, Rho D immunoglobulin administration, and autism symptom severity was collected through a maternal survey questionnaire and clinical observation. Hair mercury levels in the autistic group were 0.47 ppm versus 3.63 ppm in controls, a significant difference. The mothers in the autistic group had significantly higher levels of mercury exposure through Rho D immunoglobulin injections and amalgam fillings than control mothers. Within the autistic group, hair mercury levels varied significantly across mildly, moderately, and severely autistic children, with mean group levels of 0.79, 0.46, and 0.21 ppm, respectively. Hair mercury levels among controls were significantly correlated with the number of the mothers’ amalgam fillings and their fish consumption as well as exposure to mercury through childhood vaccines, correlations that were absent in the autistic group. Hair excretion patterns among autistic infants were significantly reduced relative to control. These data cast doubt on the efficacy of traditional hair analysis as a measure of total mercury exposure in a subset of the population. In light of the biological plausibility of mercury’s role in neurodevelopmental disorders, the present study provides further insight into one possible mechanism by which early mercury exposures could increase the risk of autism.

VAXXED TV – Vaxxed versus unvaccinated in my family

Donny’s story

I was extremely pro vaccine

MMR gave my son autism

My daughter is injured for life by the flu vaccine

I will not vaccinate my children

Doctor of infectious disease

SIDS technician

Vaxxed versus unvaccinated

5 members of my family are vaccine injured

****************************************************

How to accept Jesus Christ as your personal Saviour

Testimony by Phil Robertson from Duck Dynasty

1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:

Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.